| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2002 | WO2002029005A2 Detection of ras mutations |
| 04/11/2002 | WO2002029003A2 Massive parallel method for decoding dna and rna |
| 04/11/2002 | WO2002029002A2 Method for generating cloned animals using chromosome shuffling |
| 04/11/2002 | WO2002029000A2 Methods of minimizing immunological rejection of a nuclear transfer fetus |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028905A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028904A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028903A2 Heavy chain libraries |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028901A2 Seven-transmembrane (7tm) receptors and uses thereof |
| 04/11/2002 | WO2002028900A2 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/11/2002 | WO2002028899A1 Human prostate specific g-protein receptor hpraj70 |
| 04/11/2002 | WO2002028898A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028896A1 Analogues of human granulocite colony stimulating factor (g-csf) |
| 04/11/2002 | WO2002028893A2 Plant cyclin-dependent kinase inhibitors |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028878A1 Antisense modulation of smad6 expression |
| 04/11/2002 | WO2002028876A2 Oligonucleotide linkers comprising a variable cohesive portion and method for the preparation of polynucleotide libraries by using said linkers. |
| 04/11/2002 | WO2002028481A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | WO2002028480A2 Methods of therapy for b-cell malignancies |
| 04/11/2002 | WO2002028439A2 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 04/11/2002 | WO2002028423A1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 04/11/2002 | WO2002028420A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | WO2002028419A2 Chemokine mutants in the treatment of multiple sclerosis |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028408A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | WO2002028406A2 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | WO2002028355A2 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002028345A2 Aldehyde-releasing compounds |
| 04/11/2002 | WO2002028188A1 Derivation of human tumor cell lines using passage in transgenic mice having selectable markers |
| 04/11/2002 | WO2002028184A1 Treatment of transgenic corn seeds with clothianidin |
| 04/11/2002 | WO2002028175A2 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 04/11/2002 | WO2002028174A1 Methods of infection with hepatitis c virus |
| 04/11/2002 | WO2002028168A1 High efficiency regulatable gene expression system |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002028164A2 Cloning endangered and extinct species |
| 04/11/2002 | WO2002012538A3 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 04/11/2002 | WO2002012288A3 Vaccination against host cell-associated herpesviruses |
| 04/11/2002 | WO2002007514A3 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/11/2002 | WO2002006511A3 Methods for detecting and assaying nucleic acid sequences |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002002739A3 Ubiquitin ligase |
| 04/11/2002 | WO2002000924A3 Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
| 04/11/2002 | WO2002000898A9 Transformation system of fungus belonging to the genus monascus |
| 04/11/2002 | WO2002000891A3 Human napsin-like aspartyl protease |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001098513A3 Methods and means for the complementation of viral protein expression in stable cell lines |
| 04/11/2002 | WO2001094946A9 Microarrays for performing proteomic analyses |
| 04/11/2002 | WO2001094638A8 Asynchronous primed pcr |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092511A3 Purification of a triple heli formation with an immobilized oligonucleotide |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090391A3 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution |
| 04/11/2002 | WO2001090339A3 Methods and compositions to activate genes in cells |
| 04/11/2002 | WO2001090312A9 Ammonia-oxidizing bacteria |
| 04/11/2002 | WO2001090300A3 Snap back stealth oligonucleotide |
| 04/11/2002 | WO2001089559A3 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 04/11/2002 | WO2001088159A3 Cd28 synthebody for the modulation of immune responses |
| 04/11/2002 | WO2001087231A3 Methods and compositions for the diagnosis of schizophrenia |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001085200A3 Recombinant human cln2 protein and methods of its production and use |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001082963A3 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/11/2002 | WO2001081602A3 Mre11 orthologue and uses thereof |
| 04/11/2002 | WO2001079513A3 Process for modifying plants |
| 04/11/2002 | WO2001077353A3 Expression of pollen allergens in plastids |
| 04/11/2002 | WO2001077316A3 Method of nucleic acid recovery |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001075150A3 Biosensor, biosensor array, method for producing an electrode of a biosensor, method for producing a biosensor |
| 04/11/2002 | WO2001075107A3 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001073432A3 Method for detecting and/or quantifying first molecules |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 04/11/2002 | WO2001070971A3 Regulation of human mas oncogene-related g protein-coupled receptor |
| 04/11/2002 | WO2001070806A3 Human secreted proteins and polynucleotides encoding the same |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001068833A3 Recombinant hhv8 dna |
| 04/11/2002 | WO2001068812A3 Methods of stimulating cartilage formation |
| 04/11/2002 | WO2001066758A3 25934, a novel fatty acid desaturase and uses therefor |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2001063294A3 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001059153A3 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 04/11/2002 | WO2001059066A3 Protein design automation for protein libraries |
| 04/11/2002 | WO2001058946A3 Polynucleotides and polypeptides encoded thereby |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001057209A3 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001051647A3 Method for increasing the content of fatty acids in plants and micro-organisms |
| 04/11/2002 | WO2001036616A3 Acid nucleic construct bearing a system regulating the expression of a gene |
| 04/11/2002 | WO2001007578A3 Subtilisin protease variants having amino acid substitutions in defined epitope regions |